Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021)

Historic Asset Writedowns and Impairment for AVITA Medical (RCEL) over the last 3 years, with Q4 2021 value amounting to $23000.0.

  • AVITA Medical's Asset Writedowns and Impairment rose 56000.0% to $23000.0 in Q4 2021 from the same period last year, while for Dec 2023 it was $42000.0, marking a year-over-year change of. This contributed to the annual value of $810000.0 for FY2025, which is 6632.44% up from last year.
  • Per AVITA Medical's latest filing, its Asset Writedowns and Impairment stood at $23000.0 for Q4 2021, which was up 56000.0% from $19000.0 recorded in Q3 2021.
  • AVITA Medical's Asset Writedowns and Impairment's 5-year high stood at $23000.0 during Q4 2021, with a 5-year trough of -$77000.0 in Q3 2020.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $9500.0 (2019), whereas its average is -$3500.0.
  • Per our database at Business Quant, AVITA Medical's Asset Writedowns and Impairment plummeted by 106250.0% in 2020 and then surged by 56000.0% in 2021.
  • AVITA Medical's Asset Writedowns and Impairment (Quarter) stood at $11000.0 in 2019, then plummeted by 145.45% to -$5000.0 in 2020, then surged by 560.0% to $23000.0 in 2021.
  • Its last three reported values are $23000.0 in Q4 2021, $19000.0 for Q3 2021, and -$5000.0 during Q4 2020.